Summary
The purposes of this paper are severalfold: a) to avoid a cloak of product inference; b) to focus attention on the need to keep patients on long-term (antihypertensive) therapy with as few side effects as possible; c) to acknowledge certain arguments relating to side effects, some of which have engendered concern among respected authorities in the field; d) to underscore the validity of current health care preoccupations relating to cost containment and cost effectiveness; and e) to question the wisdom of certain governments around the world in suggesting that low-cost antihypertensive medications that are already available should be used in preference to newer and more costly drugs no matter what the theoretical or clinical justification.
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Frohlich, E.D. Life's quality: A major consideration in health care delivery — Especially with hypertensive diseases. Cardiovasc Drug Ther 3, 821–823 (1989). https://doi.org/10.1007/BF01869565
Issue Date:
DOI: https://doi.org/10.1007/BF01869565